Pharmaceutical

Ardelyx sues CMS over revamped kidney disease drug payment bundle

Ardelyx and two other organisations have filed a lawsuit, opposing the HHS' and CMS’ revamped kidney disease payment scheme.

Jul 20, 2024 - 04:00
Ardelyx sues CMS over revamped kidney disease drug payment bundle
Ardelyx and two other organisations have filed a lawsuit, opposing the HHS' and CMS’ revamped kidney disease payment scheme.
Read the original article

Tags:

Previous Article

EMA accepts Deciphera’s MAA cell tumour treatment for review

Next Article

FDA launches new rare disease innovation hub

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Risk adjusted net present value: What is the current va...

Dec 15, 2024

STAT+: The biggest health care deals of 2023

STAT+: The biggest health care deals of 2023

Dec 17, 2023

STAT+: Bristol Myers to buy cancer player Mirati for more than $4.8 billion

STAT+: Bristol Myers to buy cancer player Mirati for mo...

Oct 8, 2023